Phospholipid-dependent procoagulant activity is highly expressed by circulating microparticles in patients with essential thrombocythemia-Reference-Cited by-同舟云学术

Phospholipid-dependent procoagulant activity is highly expressed by circulating microparticles in patients with essential thrombocythemia

Published:2013-11-20 Issue:1 Volume:89 Page:68-73
ISSN:0361-8609
Container-title:American Journal of Hematology
language:en
Short-container-title:Am. J. Hematol.

Author:

Marchetti Marina¹,Tartari Carmen J.¹,Russo Laura¹,Panova-Noeva Marina¹,Leuzzi Annamaria¹,Rambaldi Alessandro²,Finazzi Guido²,Woodhams Barry³,Falanga Anna¹

Affiliation:

1. Division of Immunohematology and Transfusion Medicine; Hospital Papa Giovanni XXIII; Bergamo Italy

2. Division of Hematology; Hospital Papa Giovanni XXIII; Bergamo Italy

3. HaemaCon, Ltd.; Bromley United Kingdom

Publisher

Wiley

Subject

Hematology

Reference25 articles.

1. Polycythemia vera and essential thrombocythemia: 2012 update on diagnosis, risk stratification, and management;Tefferi;Am J Hematol,2012

2. Pathogenesis of thrombosis in essential thrombocythemia and polycythemia vera: The role of neutrophils;Falanga;Semin Hematol,2005

3. Leukocytosis, JAK2V617F mutation, and hemostasis in myeloproliferative disorders;Marchetti;Pathophysiol Haemost Thromb,2008

4. The presence of the JAK2 V617F mutation is associated with a higher haemoglobin and increased risk of thrombosis in essential thrombocythaemia;Cheung;Br J Haematol,2006

5. Association of V617F Jak2 mutation with the risk of thrombosis among patients with essential thrombocythaemia or idiopathic myelofibrosis: A systematic review;Lussana;Thromb Res,2009

Cited by 56 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Activated Factor VII–Antithrombin Complex, a Biomarker of Tissue Factor-Related Pathways in Different Clinical Settings: A Narrative Review from Cardiovascular Diseases to Cancer;Diagnostics;2024-08-06

2. JAK2V617F mutation and circulating extracellular vesicles in essential thrombocythemia;Clinical Hemorheology and Microcirculation;2023-09-20

3. Platelets from patients with myeloproliferative neoplasms have increased numbers of mitochondria that are hypersensitive to depolarization by thrombin;Scientific Reports;2023-06-06

4. The Pitfalls of Global Hemostasis Assays in Myeloproliferative Neoplasms and Future Challenges;Seminars in Thrombosis and Hemostasis;2023-04-17

5. Tissue factor activity of small and large extracellular vesicles in different diseases;Research and Practice in Thrombosis and Haemostasis;2023-03